A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Twenty‐five patients with hand tremor of 2 + (moderate) to 4 + (severe) on the tremor severity rating scale were randomized to receive either 50 U of botulinum toxin (BTX) type A (Allergan, Irvine, CA) or placebo injections into the wrist flexors and extensors of the dominant limb. If patients failed to respond to the initial injection, they were eligible to receive another injection of 100 U 4 weeks later. Rest, postural, and kinetic tremors were evaluated at 2‐ to 4‐week intervals over a 16‐week study period using tremor severity rating scales, accelerometry, and assessments of improvement and disability. A signigicant improvment (p < 0.05) was observed on the tremor severity rating scale 4 weeks after injection in patients treated with BTX as compared with placebo, and this effect was maintained for the duration of the study. Four weeks after injection, 75% of BTX‐treated patients vs. 27% of placebo‐treated patients (p < 0.05). reported mild to moderate improvement (peak effect rating ≥2). There were no significant improvements in functional rating scales, although trends were observed for some items. Postural accelerometry measurements showed a ≥30% reduction in amplitude in nine of 12 BTX‐treated subjects and in one of nine placebo‐treated subjects (p < 0. 05). Although all patients treated with BTX reported some degree of finger weakness, no severe, irreversible, or unexpected adverse events occurred. Chemodenervation with BTX may significantly ameliorate essential hand tremor in patients who fail to improve with conventional pharmacologic therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This approach has been used successfully with the advantage of providing very targeted relief (46–51).”
From Could Wearable and Mobile Technology Improve the Management of Essential Tremor? (2018) · cites this paper as [47]
Citations
Cites
The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981) · Medical Care · doi:10.1097/00005650-198108000-00001 · Cited by 4,619
Therapeutic Uses of Botulinum Toxin
Oates, J. A., Wood, A. J. J., Jankovic, J., & Brin, M. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241707 · Cited by 801
Self-citationParkinson's Disease and Movement Disorders
Kieburtz, K. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540220013003 · Cited by 616
Landis, J. R., Heyman, E. R., & Koch, G. G. (1978) · International Statistical Review / Revue Internationale de Statistique · doi:10.2307/1402373 · Cited by 454
A study of hereditary essential tremor
Bain, P. G., Findley, L. J., Thompson, P. D., Gresty, M. A., Rothwell, J. C., Harding, A. E., & Marsden, C. D. (1994) · Brain · doi:10.1093/brain/117.4.805 · Cited by 392
Tonic vibration reflex and muscle afferent block in writer's cramp
Kaji, R., Rothwell, J. C., Katayama, M., Ikeda, T., Kubori, T., Kohara, N., Mezaki, T., Shibasaki, H., & Kimura, J. (1995) · Annals of Neurology · doi:10.1002/ana.410380206 · Cited by 300
Is dystonia a sensory disorder?
Hallett, M. (1995) · Annals of Neurology · doi:10.1002/ana.410380203 · Cited by 297
Rivner, M. H. (1995) · Neurology · doi:10.1212/wnl.45.6.1244-a · Cited by 280
Anatomic guide for the electromyographer--the limbs
Delagi, E. F., & Perotto, A. (1980) · Thomas eBooks · Cited by 260
Lees, A. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.3.345-d · Cited by 255
Research works printed but not linked: 2
- Lou JS, 1991, Current neurology, 199
- Ludlow CL, 1989, Treatment of voice tremor with botulinum toxin injection [Abstract], Neurology, 39, 353
Cited by
Items 101–200 of 234
An Update on Botulinum Toxin in Neurology
Chiu, S., Burns, M. R., & Malaty, I. A. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2020.09.014 · Cited by 30
Current Uses of Botulinum Neurotoxins in Plastic Surgery
Noland, M. E., Lalonde, D. H., Yee, G. J., & Rohrich, R. J. (2016) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000002480 · Cited by 23
Focal dystonia: The role of botulinum toxin
Tintner, R., & Jankovic, J. J. (2001) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-001-0087-6 · Cited by 24
“In a placebo-controlled study [ 60 ], 25 patients with hand tremor of 2+ (moderate) to 4+ (severe) on the tremor severity rating scale were randomized to receive either 50 U of BTX or placebo injections into the wrist flexors and extensors of the dominant limb.”
MethodSelf-citationCould Wearable and Mobile Technology Improve the Management of Essential Tremor?
Daneault, J.-F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00257 · Cited by 21
Zesiewicz, T., & Kuo, S. (2015) · Europe PMC (PubMed Central) · Cited by 26
Botulinum Toxin Therapy for Parkinson's Disease
Malaty, I. A., & Shukla, A. W. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1602246 · Cited by 20
Essential tremor: Update of therapeutic strategies (medical treatment and gamma knife thalamotomy)
Witjas, T., Carron, R., Boutin, E., Eusébio, A., Azulay, J., & Régis, J. M. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.07.014 · Cited by 21
Botulinum toxin for the treatment of tremor
Mittal, S. O., & Pandey, S. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120203 · Cited by 19
Lambert, D., & Waters, C. (1999) · Current Treatment Options in Neurology · doi:10.1007/s11940-999-0027-3 · Cited by 19
Guidelines for the therapeutic use of botulinum toxin in movement disorders
Pagni, C. A., Abbruzzese, G., & Berardelli, A. (1998) · Neurological Sciences · doi:10.1007/bf00831571 · Cited by 19
Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial
Rajan, R., Srivastava, A. K., Anandapadmanabhan, R., Saini, A., Upadhyay, A., Gupta, A., Vishnu, V. Y., Pandit, A. K., Vibha, D., Singh, M. B., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.4766 · Cited by 20
Treatment of Childhood Myoclonus With Botulinum Toxin Type A
Awaad, Y. M., Tayem, H., Elgamal, A., & Coyne, M. F. (1999) · Journal of Child Neurology · doi:10.1177/088307389901401203 · Cited by 18
Tremor - Easily Seen but Difficult to Describe and Treat
Grimes, D. A. (2003) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100003255 · Cited by 20
Medical and Surgical Treatment of Tremors
Schneider, S. A., & Deuschl, G. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.09.005 · Cited by 18
Singer, C., Papapetropoulos, S., & Spielholz, N. I. (2005) · Movement Disorders · doi:10.1002/mds.20590 · Cited by 17
Zhang, J., Yan, R., Cui, Y., Su, D., & Feng, T. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102889 · Cited by 20
Zonisamide for essential tremor
Bruno, E., Nicoletti, A. S. Q., Filippini, G., Quattrocchi, G., Colosimo, C., & Zappia, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009684.pub2 · Cited by 17
Dynamic Decomposition of Motion in Essential and Parkinsonian Tremor
Rahimi, F., Debicki, D., Roberts, A., Bee, C., Bapat, P., & Jog, M. (2015) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2015.12 · Cited by 16
“While injection of BoNT A in the extremities is a viable option for the treatment of tremor,(7,11,12) it has not been indicated or widely adopted for clinical treatment, given impairment of limb function from excessive or unwanted muscle weakness.(6) As with all injections in the limbs, especially in the upper limbs,…”
BackgroundMethodLorenzano, C., Bagnato, S., Gilio, F., Fabbrini, G., & Berardelli, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033932 · Cited by 16
Louis, E. D. (2006) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2006.06.012 · Cited by 17
Treatment Patterns in Essential Tremor: A Retrospective Analysis
Shah, C. V., Jackson, G. R., Sarwar, A., Mandava, P., & Jamal, F. (2022) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.682 · Cited by 15
Clinical neurophysiology in the treatment of movement disorders: IFCN handbook chapter
Lefaucheur, J., Moro, E., Shirota, Y., Ugawa, Y., Grippe, T. C., Chen, R. E., Benninger, D. H., Jabbari, B., Attaripour, S., Hallett, M., et al. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.05.007 · Cited by 17
Reliability of tremor measurements using a multidimensional electromagnetic sensor system
Spyers-Ashby, J. M., & Stokes, M. J. (2000) · Clinical Rehabilitation · doi:10.1191/0269215500cr328oa · Cited by 15
A Pilot Efficacy and Tolerability Trial of Memantine for Essential Tremor
Handforth, A., Bordelon, Y. M., Frucht, S. J., & Quesada, A. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181ebd109 · Cited by 15
Pharmacological treatment of disabling tremor
Schadt, C. R., Duffis, E. I., & Charles, D. P. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.3.419 · Cited by 15
“3 Botulinum toxin type A Botulinum toxin type A (Botox® and Dysport®) has been shown to provide some reduction in essential hand tremor [22-24] and significant improvement in activities of daily living [23].”
BackgroundMethodHaubenberger, D., & Hallett, M. (2018) · PubMed · doi:10.1056/nejmc1807690 · Cited by 14
Validation of a precision tremor measurement system for multiple sclerosis
Perera, T., Lee, W.-L., Yohanandan, S. A. C., Nguyen, A., Cruse, B., Boonstra, F. M. C., Noffs, G., Vogel, A. P., Kolbe, S., Butzkueven, H., et al. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.09.022 · Cited by 14
O’Sullivan, J. D., & Lees, A. J. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200009000-00001 · Cited by 14
NEUROTOXIN INJECTION FOR MOVEMENT DISORDERS
Charles, D. P., & Gill, C. E. (2010) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000348904.32834.70 · Cited by 13
“…of excessive weakness (selfreported by 70% of patients from the high-dose group in one study (Brin et al, 2001) and by all patients in another (Jankovic et al, 1996) may effectively unblind participants and investigators to treatment status, and so even trials with positive results must be…”
BackgroundBotulinum toxin treatment in parkinsonism
Anandan, C., & Jankovic, J. J. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.122810 · Cited by 13
Self-citationKreisler, A., Bouchain, B., Defebvre, L., & Krystkowiak, P. C. (2019) · Tremor and Other Hyperkinetic Movements · doi:10.7916/d8-39fg-qs60 · Cited by 14
Botulinum toxin type A for hand tremor: a meta-analysis of randomised controlled trials
Zheng, X., Wei, W., Liu, P., Wu, C., Lu, L., & Tang, C. (2020) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2020.0079 · Cited by 13
Variability of hand tremor in rest and in posture — A pilot study
Rahimi, F., Bee, C., Roberts, A., Debicki, D., & Jog, M. (2011) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2011.6090067 · Cited by 16
Estrategias terapéuticas en el temblor esencial
Gironell, A. (2007) · Medicina Clínica · doi:10.1157/13111814 · Cited by 13
Alprazolam for essential tremor
Bruno, E., Nicoletti, A. S. Q., Quattrocchi, G., Filippini, G., Zappia, M., & Colosimo, C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009681.pub2 · Cited by 12
Casanovas-Cladellas, M. L., Santafé-Llopis, J. V., Pereda‐Suberbiola, J., & Santisteban-Bové, C. (2022) · Spanish Journal of Palaeontology · doi:10.7203/sjp.24103 · Cited by 13
Botulinum toxin type A in cerebellar tremor caused by multiple sclerosis
Clarke, C. E. (1997) · European Journal of Neurology · doi:10.1111/j.1468-1331.1997.tb00301.x · Cited by 11
Treatment and Management of FXTAS
Berry‐Kravis, E., Hall, D. A., Leehey, M. A., & Hagerman, R. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5805-1_9 · Cited by 13
“Placebo-controlled trials of botulinum toxin have shown reduction of essential tremor but functional improvement was limited by limb weakness ( Jankovic et al. 1996; Pacchetti et al. 2000).”
BackgroundPregabalin for essential tremor
Bruno, E., Nicoletti, A. S. Q., Quattrocchi, G., Filippini, G., Colosimo, C., & Zappia, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009682.pub2 · Cited by 11
Samotus, O., Lee, J., & Jog, M. (2021) · Toxins · doi:10.3390/toxins13040264 · Cited by 10
Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease—A Systematic Review
Jabbari, B., & Comtesse, S. M. (2023) · Toxins · doi:10.3390/toxins15020081 · Cited by 9
“Over the past 10 years, investigators have focused on new and innovative protocols that could improve Parkinson tremor while avoiding the high incidence (30–40%) of finger and hand weakness reported previously after botulinum toxin injection for treatment of essential tremor (ET) [19,20].”
BackgroundSamotus, O., Lee, J., & Jog, M. (2018) · Toxins · doi:10.3390/toxins10100394 · Cited by 9
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50022-x · Cited by 9
Self-citationTroiano, A. R., Teive, H. A. G., Fabiani, G., Zavala, J. A. A., Sá, D. S., Germiniani, F. M. B., Camargo, C. H. F., & Werneck, L. C. (2004) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2004000100015 · Cited by 9
Chapter 41 Focal injection therapy
Graciès, J., & Simpson, D. M. (2003) · Handbook of clinical neurophysiology · doi:10.1016/s1567-4231(09)70189-3 · Cited by 8
Neuropathological substrates of cognition in Parkinson's disease.
Coughlin, D., & Irwin, D. (2022) · Progress in Brain Research · doi:10.1016/bs.pbr.2022.01.014 · Cited by 7
Methodological Issues in Clinical Drug Development for Essential Tremor
Carranza, M. A., Snyder, M., Elble, R. J., Boutzoukas, A. E., & Zesiewicz, T. (2012) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.116 · Cited by 9
Ultrasound-Guided Botulinum Toxin Infiltrations in Essential Tremor Patients: A 36-week Follow Up
Salazar, G., & Saez, I. C. (2025) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.957 · Cited by 7
Guidelines for the use of botulinum toxin in movement disorders and spasticity
Borgohain, R., Jabeen, A., Kandadai, R. M., & Kannikannan, M. A. (2011) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.83099 · Cited by 7
Clinical features, assessment and treatment of essential tremor.
Panicker, J. N., & Pal, P. K. (2003) · PubMed · Cited by 10
A Pilot Study of Botulinum Toxin for Jerky, Position-Specific, Upper Limb Action Tremor
Saifee, T. A., Teodoro, T., Erro, R., Edwards, M. J., & Cordivari, C. (2016) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.292 · Cited by 7
Dash, D., Bruno, V. A., Schwingenschuh, P., Lyons, K. E., Tan, E.-K., Testa, C. M., Perez‐Lloret, S., Balint, B., Costa, J., de Bie, R. M. A., et al. (2026) · Movement Disorders · doi:10.1002/mds.70184 · Cited by 6
“25,26,28 New Commercially Available Interventions since the 2019 EBM-MDS ET Review Perampanel”
van der Lip, W., Eekhof, J., & Neven, A. K. (2005) · Huisarts en Wetenschap · doi:10.1007/bf03084273 · Cited by 6
Treatment of Dystonic Tremor of the Upper Limbs: A Single-Center Retrospective Study
González‐Herrero, B., Vico, I. A. D., Pereira, E. A. C., Edwards, M. J., & Morgante, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041427 · Cited by 6
“Previous studies using BoNT in the treatment of upper limb tremor only injected either the wrist flexors/extensors [13,14] or selected the muscles by the clinical and electrophysiological assessment of patients with arms at rest, outstretched in front of the subject, and while performing finger-to-nose action [7,15].”
BackgroundResultUse of Botulinum Toxin in Upper-Limb Tremor: Systematic Review and Perspectives
Motavasseli, D., Delorme, C., Bayle, N., Graciès, J., Roze, E. F., & Baude, M. (2024) · Toxins · doi:10.3390/toxins16090392 · Cited by 7
“The second study found a dose-dependent improvement in a patient-reported subjective scale, but not in writing, working, social embarrassment, or anxiety [19,20].”
BackgroundBotulinum Toxins: Transformation of a Toxin into a Treatment
Cornelia, C. L., Simpson, L. L., & Jankovic, J. J. (2005) · Elsevier eBooks · doi:10.1016/b978-012738903-5/50008-4 · Cited by 6
Self-citationBotulinum Toxin Monotherapy for the Treatment of Essential Tremor: Life Quality Effect
Demiryürek, B. E. (2021) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000428 · Cited by 5
Louis, E. D., & Ottman, R. (2003) · Elsevier eBooks · doi:10.1016/b978-012566652-7/50034-4 · Cited by 6
Effects of Deep Dry Needling on Tremor Severity and Functionality in Stroke: A Case Report
Ortín, J. A., Bravo-Esteban, E., Ibáñez, J., Herrero, P., Gómez‐Soriano, J., & Marcén-Román, Y. (2020) · Healthcare · doi:10.3390/healthcare9010005 · Cited by 4
“However, studies on BTX-A injections have not revealed significant changes in functionality [38,39], whereas the patient in this study experienced a decrease of 25% in the time spent to complete the 9HPT, which persisted for 4 days after the intervention, despite the fact that both BTX-A and DN seem to have central ef…”
BackgroundBotulinum Toxin Treatment in Parkinson’s Disease and Atypical Parkinsonian Disorders
Jindal, P., & Jankovic, J. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-56038-0_3 · Cited by 4
Self-citationZonisamide for essential tremor
Bruno, E., Nicoletti, A. S. Q., Quattrocchi, G., Colosimo, C., Filippini, G., & Zappia, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009684 · Cited by 4
Nagaratnam, S. A., Wilson, D., Chiang, H., Chang, F., Qiu, J. X., Silsby, M., Fois, A. F., Martin, A. J., Mahant, N., Fung, V. S. C., et al. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70079 · Cited by 3
“7 – 11 We have previously reported improvements in upper limb tremor with botulinum toxin, regardless of etiology, in a retrospective, observational open label study.”
Role of botulinum toxin in hand and upper limb disorders relevant to hand therapy
Keir, J., & Giele, H. P. (2009) · Hand Therapy · doi:10.1258/ht.2009.009010 · Cited by 3
Botulinum toxin for essential tremor
Gulati, K., & Pandey, S. (2025) · Toxicon · doi:10.1016/j.toxicon.2025.108273 · Cited by 3
Mouvements anormaux et toxine botulique en neurologie
Sangla, S., Trocello, J., Bourdain, F., Vidal, J., Gallouëdec, G., & Vidailhet, M. (2003) · Annales de Réadaptation et de Médecine Physique · doi:10.1016/s0168-6054(03)00130-2 · Cited by 3
Botulinum Neurotoxins as Therapeutics
Mehanna, R., & Jankovic, J. J. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_169 · Cited by 3
Self-citationClinical Use of Botulinum Neurotoxin: Neuromuscular Disorders
Guidubaldi, A., Bentivoglio, A. R., & Albanese, A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0261-3_3 · Cited by 5
Pregabalin for essential tremor
Bruno, E., Nicoletti, A. S. Q., Quattrocchi, G., Colosimo, C., Filippini, G., & Zappia, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009682 · Cited by 3
Botulinum Toxin for the Treatment of Tremors
Bellows, S. T., & Jankovic, J. J. (2025) · Toxins · doi:10.3390/toxins17080401 · Cited by 2
“Wrist flexion/extension has long been a primary tremor axis targeted for injections [16,18,19], with some series nearly solely focusing on wrist flexor injections [26].”
InfluentialSelf-citationLongardner, K., & Haubenberger, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00031-1 · Cited by 2
Botulinum toxin for motor disorders
Safarpour, D., & Jabbari, B. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00003-x · Cited by 3
Therapy with botulinum neurotoxin for Parkinson’s disease
Jost, W. H., & Berberovic, E. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02805-y · Cited by 2
“Two studies with a fixed dose of BoNT were able to achieve an improvement in essential tremor, but failed to demonstrate a functional advantage because a paralysis occurred in the injected muscles (Jankovic et al. 1996; Brin et al. 2001 ).”
Botulinum toxin in tic disorders and essential hand and head tremor
Sheffield, J. K., & Jankovic, J. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511575761.025 · Cited by 2
Self-citationBotulinum Neurotoxin in Tremors, Tics, Hemifacial Spasm, Spasmodic Dysphonia, and Stuttering
Bentivoglio, A. R., Fasano, A. A., & Albanese, A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4928-9.00010-x · Cited by 4
The History of Essential Tremor
DiDio, A., & Koller, W. C. (2005) · Neurological disease and therapy · doi:10.1201/b14115-3 · Cited by 2
The use of botulinum neurotoxin in tic disorders and essential hand and head tremor
Jankovic, J. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139178068.019 · Cited by 2
Self-citationFahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00018-4 · Cited by 2
Self-citationRaethjen, J., & Volkmann, J. (2004) · Steinkopff eBooks · doi:10.1007/978-3-7985-1956-5_9 · Cited by 2
Botulinum Toxins in the Treatment of Dystonia
Stacy, M. A. (2006) · Medical psychiatry · doi:10.3109/9781420019988.023 · Cited by 2
6: Movement disorders II: The hyperkinetic disorders
Rice, J., & Thompson, P. D. (2001) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2001.tb143349.x · Cited by 2
Topiramate for essential tremor
Bruno, E., Nicoletti, A. S. Q., Quattrocchi, G., Allegra, R., Colosimo, C., Filippini, G., & Zappia, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009683 · Cited by 2
Alprazolam for essential tremor
Bruno, E., Nicoletti, A. S. Q., Quattrocchi, G., Colosimo, C., Filippini, G., & Zappia, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009681 · Cited by 2
Botulinum Toxin Efficacy in Upper Limb Tremor: A Systematic Review and Meta‐Analysis
Visser, I. M., Pitakpatapee, Y., van de Warrenburg, B. P. C., Helmich, R. C. G., Snijders, A. H., & Nijhuis, F. A. P. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70307 · Cited by 1
“Five RCTs compared the effects of BoNT injections to placebo, 16 – 18, 24, 32 The pooled between-group SMD for patient-reported changes was 0.58 [95% CI: 0.39, 0.78], suggesting a moderate effect (Fig.”
InfluentialRabe, Y. J., Yu, A. B., Yu, J. R. T., & Simpson, D. M. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-03029-4 · Cited by 1
Therapie der fokalen Spastik mit Botulinumtoxin
Ceballos-Baumann, A., & Messner, M. (2008) · Nervenheilkunde · doi:10.1055/s-0038-1627352 · Cited by 1
Rana, A. Q., & Chou, K. L. (2015) · In clinical practice · doi:10.1007/978-3-319-14598-3_5 · Cited by 1
Peripheralsurgical and movement modification therapies for movement disorders
Rawicki, B. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139012942.006 · Cited by 1
A Neurotoxin Which is Used for Health – How it all Began?
Jabbari, B. (2018) · Springer eBooks · doi:10.1007/978-3-319-99945-6_1 · Cited by 1
Recent Updates on Essential Tremor
Jamal, F. (2019) · International Journal of Neurology and Neurotherapy · doi:10.23937/2378-3001/1410081 · Cited by 1
Botulinum Neurotoxins as a Therapeutic
Mehanna, R., & Jankovic, J. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_169-1 · Cited by 1
Self-citationBarbano, R. L., Simpson, D. M., Patterson, K. P., Alibhai, N., & James, L. M. (2024) · Toxicon · doi:10.1016/j.toxicon.2024.107362 · Cited by 1
Other clinical neurological uses of botulinum toxin
Barnes, M. P. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544842.016
Chapter 10 Hyperkinetic Movement Disorders
Hristova, A. H., & Koller, W. C. (2001) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70017-0
Dalvi, A. (2011) · Disease-a-Month · doi:10.1016/j.disamonth.2011.02.006 · Cited by 1
Louis, E. D. (2005) · Elsevier eBooks · doi:10.1016/b978-012088382-0/50031-1
Botulinum toxins in the treatment of dystonia
Stacy, M. A., & Hickey, P. (2012) · CRC Press eBooks · doi:10.3109/9781841848525-29
Medical Treatment of Essential Tremor
Pahwa, A. (2005) · Neurological disease and therapy · doi:10.1201/b14115-12
Iansek, R., & Morris, M. E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139012942.004
van der Lip, W. (2016) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-1082-1_9
Samotus, O. (2016) · Scholarship@Western (Western University) · Cited by 1
Metadata
- Authors
- Jankovic, J., Schwartz, K., Clemence, W., Aswad, A., & Mordaunt, J.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Jankovic, J.
- ORCID
- Jankovic, J.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 1996-05
- Volume
- 11
- Issue
- 3
- Pages
- 250-256
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2010076187
- Cited by
- 235
- References
- 15
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 9 · 2023: 7 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 8 · 2018: 9 · 2017: 12 · 2016: 10 · 2015: 7 · 2014: 5 · 2013: 8 · 2012: 10
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Keywords
- botulinum toxin type A, wrist flexors, wrist extensors, accelerometry, postural tremor, kinetic tremor, chemodenervation
- MeSH terms
- Aged, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Electromyography, Female, Hand, Humans, Injections, Intramuscular, Male, Middle Aged, Motor Skills, Neurologic Examination, Signal Processing, Computer-Assisted, Tremor, Treatment Outcome, Botulinum Toxins, Type A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.